Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OEDEME study of furosemide plus empagliflozin for MET inhibitor-induced edema
jRCT1041260050Recruiting
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of furosemide and empagliflozin in peripheral edema and heart failure (HF). Started Jul 2026; status: recruiting.
02
Drugs
furosemideempagliflozin
03
Conditions
peripheral edemaheart failure (HF)
Beyond the preview
Go deeper on jRCT1041260050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1041260050.